167 related articles for article (PubMed ID: 6579009)
1. Petasitenine.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():207-12. PubMed ID: 6579009
[No Abstract] [Full Text] [Related]
2. Senkirkine.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():231-8. PubMed ID: 6579011
[No Abstract] [Full Text] [Related]
3. Carrageenan.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():79-94. PubMed ID: 6579019
[No Abstract] [Full Text] [Related]
4. Some toxic properties of a carcinogenic pyrrolizidine alkaloid, petasitenine.
Mori H; Kawai K; Ohbayashi F; Bunai Y; Yamada K; Hirono I
J Toxicol Sci; 1984 May; 9(2):143-9. PubMed ID: 6481824
[TBL] [Abstract][Full Text] [Related]
5. Symphytine.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():239-45. PubMed ID: 6579012
[No Abstract] [Full Text] [Related]
6. Quercetin.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():213-29. PubMed ID: 6579010
[No Abstract] [Full Text] [Related]
7. Final report on carcinogens background document for riddelliine.
National Toxicology Program
Rep Carcinog Backgr Doc; 2008 Aug; (8-5977):i-104. PubMed ID: 20737008
[No Abstract] [Full Text] [Related]
8. Gyromitrin (acetaldehyde formylmethylhydrazone).
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():163-70. PubMed ID: 6579004
[No Abstract] [Full Text] [Related]
9. Ochratoxin A.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():191-206. PubMed ID: 6579008
[No Abstract] [Full Text] [Related]
10. Furazolidone.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():141-51. PubMed ID: 6579002
[No Abstract] [Full Text] [Related]
11. 2-amino-5-nitrothiazole.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():71-7. PubMed ID: 6579018
[No Abstract] [Full Text] [Related]
12. AF-2 [2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide].
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():47-61. PubMed ID: 6579016
[No Abstract] [Full Text] [Related]
13. Cinnamyl anthranilate.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():133-9. PubMed ID: 6579001
[No Abstract] [Full Text] [Related]
14. Metabolic profiles for the pyrrolizidine alkaloid neopetasitenine and its metabolite petasitenine in humans extrapolated from rat in vivo and in vitro data sets using a simplified physiologically based pharmacokinetic model.
Yanagi M; Kamiya Y; Murayama N; Banju K; Shimizu M; Yamazaki H
J Toxicol Sci; 2021; 46(9):391-399. PubMed ID: 34470991
[TBL] [Abstract][Full Text] [Related]
15. Mineral oils (lubricant base oils and derived products).
IARC Monogr Eval Carcinog Risk Chem Hum; 1984 Apr; 33():87-168. PubMed ID: 6590457
[No Abstract] [Full Text] [Related]
16. Carcinogenic activity of petasitenine, a new pyrrolizidine alkaloid isolated from Petasites japonicus Maxim.
Hirono I; Mori H; Yamada K; Hirata Y; Haga M
J Natl Cancer Inst; 1977 Apr; 58(4):1155-7. PubMed ID: 191625
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():95-132. PubMed ID: 6579020
[No Abstract] [Full Text] [Related]
18. Bacterial mutagenicity of natural materials, pyrolysis products and additives in foodstuffs and their association with genotoxic effects in mammals.
Sugimura T; Sato S
Dev Toxicol Environ Sci; 1983; 11():115-33. PubMed ID: 6376055
[No Abstract] [Full Text] [Related]
19. Carcinogenic and mutagenic activity of an alkaloidal extract of Senecio nemorensis ssp. fuchsii.
Habs H; Habs M; Marquardt H; Röder E; Schmähl D; Wiedenfeld H
Arzneimittelforschung; 1982; 32(2):144-8. PubMed ID: 7199918
[TBL] [Abstract][Full Text] [Related]
20. Kaempferol.
IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Jul; 31():171-8. PubMed ID: 6579005
[No Abstract] [Full Text] [Related]
[Next] [New Search]
